Trimetazidine Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury by Promoting AMP-activated Protein Kinase–dependent Autophagic Flux-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trimetazidine Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury by Promoting AMP-activated Protein Kinase–dependent Autophagic Flux

Published:2017-06 Issue:6 Volume:69 Page:389-397
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Zhong Yongkang,Zhong Peiyao,He Shangfei,Zhang Ya,Tang Lu,Ling Yuanna,Fu Shanshan,Tang Ying,Yang Pingzhen,Luo Tao,Chen Baihe,Chen Aihua,Wang Xianbao

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference33 articles.

1. Chronic stable coronary artery disease: drugs vs. revascularization;Simoons;Eur Heart J.,2010

2. Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models;Ogura;Circulation,2012

3. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase;Kantor;Circ Res.,2000

4. Trimetazidine inhibits cardiomyocyte apoptosis in a rabbit model of ischemia-reperfusion;Ruixing;Transl Res.,2007

5. Trimetazidine protects cardiomyocytes against hypoxia-induced injury through ameliorates calcium homeostasis;Wei;Chem Biol Interact.,2015

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trimetazidine attenuates Ischemia/Reperfusion-Induced myocardial ferroptosis by modulating the Sirt3/Nrf2-GSH system and reducing Oxidative/Nitrative stress;Biochemical Pharmacology;2024-11

2. The Antioxidant Properties and Cardiovascular, Antidiabetic, and Renal Effects of Trimetazidine Described in Research on Experimental Models;Current Reviews in Clinical and Experimental Pharmacology;2024-08-20

3. SIRT1 is a regulator of autophagy: Implications for the progression and treatment of myocardial ischemia-reperfusion;Pharmacological Research;2024-01

4. Trimetazidine Attenuates Ischemia/Reperfusion-Induced Myocardial Ferroptosis by Modulating the Sirt3/Nrf2-GSH System and Reducing Mitochondrial Oxidative Stress;2023-10-18

5. Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine;Molecular Psychiatry;2023-06-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3